Literature DB >> 14999645

Active or prior GB virus C infection does not protect against vertical transmission of HIV in coinfected women from Tanzania.

Amy C Weintrob1, John D Hamilton, Christine Hahn, Donna Klinzman, Gustav Moyo, Dietmar Zdunek, Georg Hess, Daniel K Benjamin, Jack T Stapleton.   

Abstract

To determine whether GB virus C (GBV-C) infection is associated with protection against vertical transmission of human immunodeficiency virus (HIV), we tested 186 HIV-positive pregnant women for GBV-C. Neither active nor prior GBV-C infection was associated with a lower rate of HIV acquisition among infants. Thus, GBV-C does not appear to protect against perinatal HIV acquisition.

Entities:  

Mesh:

Year:  2004        PMID: 14999645     DOI: 10.1086/382079

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  5 in total

Review 1.  GB virus type C: a beneficial infection?

Authors:  Jack T Stapleton; Carolyn F Williams; Jinhua Xiang
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

2.  Effect of primer selection on estimates of GB virus C (GBV-C) prevalence and response to antiretroviral therapy for optimal testing for GBV-C viremia.

Authors:  I E Souza; J B Allen; J Xiang; D Klinzman; R Diaz; S Zhang; K Chaloner; D Zdunek; G Hess; C F Williams; L Benning; J T Stapleton
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

Review 3.  What you need to know about GB virus C.

Authors:  Sarah L George; Dino Varmaz
Journal:  Curr Gastroenterol Rep       Date:  2005-02

Review 4.  Review of human pegivirus: Prevalence, transmission, pathogenesis, and clinical implication.

Authors:  Yaqi Yu; Zhenzhou Wan; Jian-Hua Wang; Xianguang Yang; Chiyu Zhang
Journal:  Virulence       Date:  2022-12       Impact factor: 5.882

5.  GB Virus C (GBV-C) Infection in Hepatitis C Virus (HCV) Seropositive Women with or at Risk for HIV Infection.

Authors:  Jason T Blackard; Gang Ma; Jeffrey A Welge; Caroline C King; Lynn E Taylor; Kenneth H Mayer; Robert S Klein; David D Celentano; Jack D Sobel; Denise J Jamieson; Lytt Gardner
Journal:  PLoS One       Date:  2014-12-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.